|
US7790699B2
(en)
|
2004-10-12 |
2010-09-07 |
Fmc Biopolymer As |
Self-gelling alginate systems and uses thereof
|
|
CN101273024A
(zh)
|
2005-07-29 |
2008-09-24 |
康瑟特制药公司 |
新颖苯并[d][1,3]-二氧杂环戊烯衍生物
|
|
US8796267B2
(en)
|
2006-10-23 |
2014-08-05 |
Concert Pharmaceuticals, Inc. |
Oxazolidinone derivatives and methods of use
|
|
WO2008088727A2
(en)
|
2007-01-12 |
2008-07-24 |
Concert Pharmaceuticals, Inc. |
Endothelin receptor antagonists
|
|
US8080549B2
(en)
|
2007-01-12 |
2011-12-20 |
Concert Pharmaceuticals, Inc. |
Endothelin receptor antagonists
|
|
US8013007B2
(en)
|
2007-02-26 |
2011-09-06 |
Concert Pharmaceuticals, Inc. |
Alpha 1A-adrenoceptor antagonists
|
|
WO2008109175A1
(en)
|
2007-03-07 |
2008-09-12 |
Concert Pharmaceuticals, Inc. |
Deuterated piperazine derivatives as anti-anginal compounds
|
|
CA2681628C
(en)
|
2007-03-16 |
2016-10-18 |
Concert Pharmaceuticals, Inc. |
Inhibitors of cholesterol ester transfer protein
|
|
US8198305B2
(en)
|
2007-04-13 |
2012-06-12 |
Concert Pharmaceuticals Inc. |
1,2-benzisoxazol-3-yl compounds
|
|
US8349817B2
(en)
|
2007-04-25 |
2013-01-08 |
Concert Pharmaceuticals, Inc. |
Analogues of cilostazol
|
|
ES2401914T3
(es)
|
2007-04-25 |
2013-04-25 |
Concert Pharmaceuticals Inc. |
Análogos de Cilostazol
|
|
DK2792662T3
(da)
|
2007-05-01 |
2016-07-25 |
Concert Pharmaceuticals Inc |
Morphinanforbindelser
|
|
MX370608B
(es)
|
2007-05-01 |
2019-12-18 |
Concert Pharmaceuticals Inc |
Compuestos de morfinano.
|
|
WO2008141021A1
(en)
|
2007-05-08 |
2008-11-20 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of tetrahydrotriazolopyrazine compounds and their use as dpp-iv inhibitors
|
|
MX2009013565A
(es)
|
2007-06-12 |
2010-06-02 |
Concert Pharmaceuticals Inc |
Derivados de azapeptidos.
|
|
US7687509B2
(en)
|
2007-07-09 |
2010-03-30 |
Concert Pharmaceuticals Inc. |
Pyrimidinecarboxamide derivatives
|
|
JP5389028B2
(ja)
|
2007-08-14 |
2014-01-15 |
コンサート ファーマシューティカルズ インコーポレイテッド |
置換オキサゾリジノン誘導体
|
|
JP2010537717A
(ja)
|
2007-08-28 |
2010-12-09 |
エフ エム シー コーポレーション |
遅効性自己ゲル化アルギネートシステムおよびその用途
|
|
MX2010002679A
(es)
|
2007-09-12 |
2010-03-29 |
Concert Pharmaceuticals Inc |
Derivados de 4-oxoquinolina deuterados para el tratamiento de la infeccion por el virus de inmunodeficiencia humana.
|
|
JP5647519B2
(ja)
|
2007-09-13 |
2014-12-24 |
コンサート ファーマシューティカルズ インコーポレイテッド |
重水素化カテコールおよびベンゾ[d][1,3]ジオキソールおよびその誘導体の合成
|
|
EP2212298B1
(en)
|
2007-10-18 |
2013-03-27 |
Concert Pharmaceuticals Inc. |
Deuterated etravirine
|
|
US8592487B2
(en)
|
2007-10-26 |
2013-11-26 |
Concert Pharmaceuticals, Inc. |
Deuterated darunavir
|
|
US8084464B2
(en)
|
2007-12-18 |
2011-12-27 |
Concert Pharmaceuticals, Inc. |
Tetrahydroisoquinoline derivatives
|
|
US8609673B2
(en)
|
2008-01-22 |
2013-12-17 |
Concert Pharmaceuticals, Inc. |
Vandetanib derivatives
|
|
US7855204B2
(en)
|
2008-01-22 |
2010-12-21 |
Concert Pharmaceuticals Inc. |
Derivatives of gefitinib
|
|
KR20100121527A
(ko)
|
2008-02-29 |
2010-11-17 |
콘서트 파마슈티컬즈, 인크. |
치환된 잔틴 유도체
|
|
WO2009128947A1
(en)
|
2008-04-17 |
2009-10-22 |
Concert Pharmaceuticals, Inc. |
Piperazine derivatives
|
|
WO2009154754A2
(en)
|
2008-06-17 |
2009-12-23 |
Concert Pharmaceuticals, Inc. |
Synthesis of deuterated morpholine derivatives
|
|
HRP20140195T1
(hr)
|
2008-08-29 |
2014-04-11 |
Concert Pharmaceuticals Inc. |
Supstituirani derivati triazolopiridazina
|
|
EP2334621A1
(en)
|
2008-09-16 |
2011-06-22 |
Concert Pharmaceuticals, Inc. |
Deuterated 2-amino-3-hydroxypropanoic acid derivatives
|
|
JP5730769B2
(ja)
|
2008-09-19 |
2015-06-10 |
コンサート ファーマシューティカルズ インコーポレイテッド |
モルヒナン化合物
|
|
US9045453B2
(en)
|
2008-11-14 |
2015-06-02 |
Concert Pharmaceuticals, Inc. |
Substituted dioxopiperidinyl phthalimide derivatives
|
|
EP2400953A1
(en)
*
|
2009-02-24 |
2012-01-04 |
Novartis AG |
Uses of nk receptor antagonists
|
|
US8263601B2
(en)
|
2009-02-27 |
2012-09-11 |
Concert Pharmaceuticals, Inc. |
Deuterium substituted xanthine derivatives
|
|
DE102009001446A1
(de)
|
2009-03-10 |
2010-09-23 |
Evonik Rohmax Additives Gmbh |
Verwendung von Kammpolymeren als Antifatigue-Additive
|
|
WO2010107791A2
(en)
|
2009-03-17 |
2010-09-23 |
Concert Pharmaceuticals, Inc. |
Pyrazinoisoquinoline compounds
|
|
WO2010108103A1
(en)
*
|
2009-03-19 |
2010-09-23 |
Concert Pharmaceuticals, Inc. |
Azepan-2-one derivatives
|
|
CA2759251C
(en)
|
2009-04-23 |
2017-01-03 |
Concert Pharmaceuticals, Inc. |
4-hydroxybutyric acid analogs
|
|
WO2010135579A1
(en)
|
2009-05-22 |
2010-11-25 |
Concert Pharmaceuticals, Inc. |
Fluorinated diaryl urea derivatives
|
|
CA2765015C
(en)
|
2009-06-18 |
2020-05-05 |
Concert Pharmaceuticals, Inc. |
Deuterated isoindoline-1,3-dione derivatives as pde4 and tnf-alpha inhibitors
|
|
EP2454259A1
(en)
|
2009-06-23 |
2012-05-23 |
Concert Pharmaceuticals Inc. |
Deuterium-modified triazolo-pyridazine derivatives as gaba-a receptor modulators
|
|
US8557815B2
(en)
|
2009-08-14 |
2013-10-15 |
Concert Pharmaceuticals, Inc. |
Substituted triazolophthalazine derivatives
|
|
CA2771331A1
(en)
|
2009-09-02 |
2011-03-10 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
|
WO2011028820A1
(en)
|
2009-09-02 |
2011-03-10 |
Concert Pharmaceuticals, Inc. |
Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
|
|
US8278460B2
(en)
|
2009-10-15 |
2012-10-02 |
Concert Pharmaceuticals, Inc. |
Substituted benzimidazoles
|
|
WO2011063001A1
(en)
|
2009-11-18 |
2011-05-26 |
Concert Pharmaceuticals, Inc. |
Niacin prodrugs and deuterated versions thereof
|
|
DE102010001040A1
(de)
|
2010-01-20 |
2011-07-21 |
Evonik RohMax Additives GmbH, 64293 |
(Meth)acrylat-Polymere zur Verbesserung des Viskositätsindexes
|
|
EP3144296A1
(en)
|
2010-03-02 |
2017-03-22 |
Concert Pharmaceuticals, Inc. |
Deuterated tetrahydronaphthalene derivatives
|
|
US8575361B2
(en)
|
2010-03-02 |
2013-11-05 |
Concert Pharmaceuticals Inc. |
Tetrahydronaphthalene derivatives
|
|
US9226801B2
(en)
*
|
2010-03-08 |
2016-01-05 |
Ibur, Llc |
Custom linkable imaging and multifunctional tray
|
|
US8575221B2
(en)
|
2010-03-17 |
2013-11-05 |
Concert Pharmaceuticals, Inc. |
Derivatives of dimethylcurcumin
|
|
US9107922B2
(en)
|
2010-07-16 |
2015-08-18 |
Concert Pharmaceuticals, Inc. |
Pyrimidinecarboxamide derivatives
|
|
US9074233B2
(en)
|
2010-09-01 |
2015-07-07 |
Concert Pharmaceuticals, Inc. |
Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
|
|
WO2012031072A1
(en)
|
2010-09-01 |
2012-03-08 |
Concert Pharmaceuticals, Inc. |
Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
|
|
BR112013020620A2
(pt)
|
2011-02-14 |
2016-10-04 |
Concert Pharmaceuticals Inc |
análogos de ácido 4-hidroxibutírico
|
|
US9145390B2
(en)
|
2011-03-03 |
2015-09-29 |
Concert Pharmaceuticals, Inc. |
Derivatives of pyrazole-substituted amino-heteroaryl compounds
|
|
WO2012122028A2
(en)
|
2011-03-04 |
2012-09-13 |
Concert Pharmaceuticals Inc. |
Pyrazinoisoquinoline compounds
|
|
HUE047354T2
(hu)
|
2011-05-18 |
2020-04-28 |
Vertex Pharmaceuticals Europe Ltd |
Ivacaftor deuterizált származékai
|
|
CN104364255A
(zh)
|
2012-04-13 |
2015-02-18 |
康塞特医药品有限公司 |
取代的黄嘌呤衍生物
|
|
EP2838879A1
(en)
|
2012-04-20 |
2015-02-25 |
Concert Pharmaceuticals Inc. |
Deuterated rigosertib
|
|
EP3450434B1
(en)
|
2012-06-15 |
2021-02-24 |
CoNCERT Pharmaceuticals, Inc. |
Deuterated derivatives of ruxolitinib
|
|
WO2014008417A1
(en)
|
2012-07-04 |
2014-01-09 |
Concert Pharmaceuticals, Inc. |
Deuterated vercirnon
|
|
CA2908929C
(en)
|
2012-07-12 |
2021-01-26 |
Concert Pharmaceuticals, Inc. |
Deuterated idebenone
|
|
CA2879400A1
(en)
|
2012-07-30 |
2014-02-06 |
Concert Pharmaceuticals, Inc. |
Deuterated ibrutinib
|
|
BR112015003153A2
(pt)
|
2012-08-17 |
2017-07-04 |
Concert Pharmaceuticals Inc |
baricitinib deuterado
|
|
EP2922838B1
(en)
|
2012-10-22 |
2018-03-14 |
Concert Pharmaceuticals Inc. |
Solid forms of {s-3-(4-amino-1-oxo-isoindolin-2-yl)(piperidine-3,4,4,5,5-d5)-2,6-dione} .
|
|
MX2015008829A
(es)
|
2013-01-09 |
2016-04-25 |
Concert Pharmaceuticals Inc |
Momelotinib deuterado.
|
|
WO2014150043A1
(en)
|
2013-03-15 |
2014-09-25 |
Concert Pharmaceuticals Inc. |
Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase
|
|
US9198898B2
(en)
|
2013-06-24 |
2015-12-01 |
Tigercat Pharma, Inc. |
Use of NK-1 receptor antagonists in pruritus
|
|
US8906951B1
(en)
|
2013-06-24 |
2014-12-09 |
Tigercat Pharma, Inc. |
Use of NK-1 receptor antagonists in pruritus
|
|
US9676790B2
(en)
|
2013-08-30 |
2017-06-13 |
Concert Pharmaceuticals, Inc. |
Substituted thienotriazolodiazapines
|
|
WO2015120393A1
(en)
|
2014-02-10 |
2015-08-13 |
Concert Pharmaceuticals, Inc. |
Substituted triazolobenzodiazepines
|
|
US10160778B2
(en)
|
2014-10-27 |
2018-12-25 |
Concert Pharmaceuticals, Inc. |
Pyrimidine phosphonic acid esters
|
|
US10196384B2
(en)
|
2015-03-31 |
2019-02-05 |
Vertex Pharmaceuticals (Europe) Limited |
Deuterated CFTR modulators
|
|
WO2016176335A1
(en)
|
2015-04-27 |
2016-11-03 |
Concert Pharmaceuticals, Inc. |
Deuterated otx-015
|
|
HK1258473A1
(zh)
|
2015-09-25 |
2019-11-15 |
Vertex Pharmaceuticals (Europe) Limited |
氘代cftr增效剂
|
|
EP3377179B1
(en)
|
2015-11-19 |
2021-04-07 |
Concert Pharmaceuticals Inc. |
Deuterated epi-743
|
|
US10442761B2
(en)
|
2016-02-16 |
2019-10-15 |
Concert Pharmaceuticals, Inc. |
Deuterated GFT-505
|
|
CA3082834A1
(en)
|
2017-11-22 |
2019-05-31 |
Concert Pharmaceuticals, Inc. |
Deuterated analogs of d-serine and uses thereof
|
|
WO2019109021A1
(en)
|
2017-12-01 |
2019-06-06 |
Vertex Pharmaceuticals Incorporated |
Processes for making modulators of cystic fibrosis transmembrane conductance regulator
|
|
WO2020206367A1
(en)
|
2019-04-03 |
2020-10-08 |
Concert Pharmaceuticals, Inc. |
Processes for the preparation of deuterated d-serine
|